0001415889-19-000144.txt : 20190211 0001415889-19-000144.hdr.sgml : 20190211 20190211160514 ACCESSION NUMBER: 0001415889-19-000144 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190207 FILED AS OF DATE: 20190211 DATE AS OF CHANGE: 20190211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOUGHLIN JAMES J CENTRAL INDEX KEY: 0001276550 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 19585386 MAIL ADDRESS: STREET 1: DORSEY & WHITNEY LLP STREET 2: 250 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10177 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 form4-02112019_040201.xml X0306 4 2019-02-07 0000816284 CELGENE CORP /DE/ CELG 0001276550 LOUGHLIN JAMES J C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 true false false false Common Stock 2019-02-07 4 M 0 24666 22.47 A 62102 D Common Stock 2019-02-07 4 S 0 23466 87.289 D 38636 D Common Stock 1800 I Family Trust Stock Option (right to buy) 22.47 2019-02-07 4 M 0 24666 D 2019-06-17 Common Stock 24666 0 D The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $87.28 to $87.30, inclusive. The reporting person undertakes to provide Celgene Corporation (the "Company"), any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The option was fully exercisable. The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan). /s/ Mark J. Alles, Attorney-in-Fact 2019-02-11